Aurobindo Pharma | ARBP - Ebitda

Stock Price
1,333.20
Daily Change
-1.90 -0.14%
Monthly
6.91%
Yearly
26.19%
Q2 Forecast
1,306.83

Aurobindo Pharma reported INR17.73B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Cipla INR 12.55B 6.4B Dec/2025
Divis Laboratories Ltd INR 8.9B 20M Dec/2025
Dr.Reddys Laboratories INR 20.89B 117M Dec/2025
Hindustan Unilever INR 37.88B 590M Dec/2025
Sun Pharmaceuticals INR 49.48B 8.52B Dec/2025
UPL INR 23.17B 1.12B Dec/2025